BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Verma A, Khorsandi SE, Dolcet A, Prachalias A, Suddle A, Heaton N, Jassem W. Low prevalence and disease severity of COVID-19 in post-liver transplant recipients-A single centre experience. Liver Int 2020;40:1972-6. [PMID: 32471013 DOI: 10.1111/liv.14552] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Giorgakis E, Zehtaban SP, Stevens AE, Bhusal S, Burdine L. COVID-19 in solid organ transplant recipients. Transpl Infect Dis 2021;23:e13419. [PMID: 32667723 DOI: 10.1111/tid.13419] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 An W, Wang Q, Kim T, Kang J. Clinical characteristics and outcome of coronavirus disease 2019 infection in patients with solid organ transplants: A systematic review and meta-analysis. Journal of Infection and Public Health 2022. [DOI: 10.1016/j.jiph.2022.02.002] [Reference Citation Analysis]
3 Campos-Varela I, Len O, Villagrasa A, Márquez-Algaba E, Esperalba J, Dopazo C, Los-Arcos I, Antón A, Castells L. Low seroprevalence of SARS-CoV-2 antibodies in a liver transplant cohort. Transpl Int 2021. [PMID: 34121244 DOI: 10.1111/tri.13946] [Reference Citation Analysis]
4 Loinaz-Segurola C, Marcacuzco-Quinto A, Fernández-Ruiz M. Coronavirus disease 2019 in liver transplant patients: Clinical and therapeutic aspects. World J Hepatol 2021; 13(10): 1299-1315 [PMID: 34786167 DOI: 10.4254/wjh.v13.i10.1299] [Reference Citation Analysis]
5 Spini A, Giudice V, Brancaleone V, Morgese MG, De Francia S, Filippelli A, Ruggieri A, Ziche M, Ortona E, Cignarella A, Trabace L. Sex-tailored pharmacology and COVID-19: Next steps towards appropriateness and health equity. Pharmacol Res 2021;173:105848. [PMID: 34454035 DOI: 10.1016/j.phrs.2021.105848] [Reference Citation Analysis]
6 Yadav DK, Adhikari VP, Ling Q, Liang T. Immunosuppressants in Liver Transplant Recipients With Coronavirus Disease 2019: Capability or Catastrophe?-A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:756922. [PMID: 34859012 DOI: 10.3389/fmed.2021.756922] [Reference Citation Analysis]
7 Musaoğlu M, Yuksel M, Mizikoglu O, Arikan C. Telemedicine in monitoring pediatric LT patients before and during COVID-19 pandemic. Pediatr Transplant 2021;:e14138. [PMID: 34505750 DOI: 10.1111/petr.14138] [Reference Citation Analysis]
8 Verma A, Khorsandi SE, Dolcet A, Prachalias A, Suddle A, Heaton N, Jassem W. Low prevalence and disease severity of COVID-19 in post-liver transplant recipients-A single centre experience. Liver Int 2020;40:1972-6. [PMID: 32471013 DOI: 10.1111/liv.14552] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
9 Mohseni M, Albus M, Kaminski A, Harrison MF. A Case of COVID-19 Re-Infection in a Liver Transplant Patient. Cureus 2021;13:e14916. [PMID: 34113522 DOI: 10.7759/cureus.14916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Karruli A, Spiezia S, Boccia F, Gagliardi M, Patauner F, Salemme A, Maiello C, Zampino R, Durante-Mangoni E. Effect of immunosuppression maintenance in solid organ transplant recipients with COVID-19: Systematic review and meta-analysis. Transpl Infect Dis 2021;:e13595. [PMID: 33641202 DOI: 10.1111/tid.13595] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Jaduan SS, Singh SA, Madan K, Gupta S. SARS-CoV-2 infection in Liver Transplant recipients - Immunosuppression is the silver lining? J Clin Exp Hepatol 2021. [PMID: 34305351 DOI: 10.1016/j.jceh.2021.07.005] [Reference Citation Analysis]
12 Weiss MJ, Hornby L, Foroutan F, Belga S, Bernier S, Bhat M, Buchan CA, Gagnon M, Hardman G, Ibrahim M, Luo C, Luong ML, Mainra R, Manara AR, Sapir-Pichhadze R, Shalhoub S, Shaver T, Singh JM, Srinathan S, Thomas I, Wilson LC, Wilson TM, Wright A, Mah A. Clinical Practice Guideline for Solid Organ Donation and Transplantation During the COVID-19 Pandemic. Transplant Direct 2021;7:e755. [PMID: 34514110 DOI: 10.1097/TXD.0000000000001199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Parente A, Manzia TM, Angelico R, Tirotta F, Muiesan P, Tisone G, Framarino Dei Malatesta M. COVID-19, liver transplant, and immunosuppression: Allies or foes? Transpl Infect Dis 2021;23:e13417. [PMID: 32666588 DOI: 10.1111/tid.13417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Altunisik Toplu S, Bayindir Y, Yilmaz S, Yalçınsoy M, Otlu B, Kose A, Sahin TT, Akbulut S, Isik B, Başkiran A, Koc C. Short-term experiences of a liver transplant centre before and after the COVID-19 pandemic. Int J Clin Pract 2021;:e14668. [PMID: 34327793 DOI: 10.1111/ijcp.14668] [Reference Citation Analysis]
15 Philips CA, Rela M, Soin AS, Gupta S, Surendran S, Augustine P. Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients. J Clin Transl Hepatol 2021;9:947-59. [PMID: 34966658 DOI: 10.14218/JCTH.2021.00228] [Reference Citation Analysis]